Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

Days after he sent letters instructing top pharmaceutical manufacturers to use a “most favored nation” pricing model for ...

But this year, the birthday of Medicaid and Medicare is more an occasion for worry than celebration. Recent changes signed ...

As investors and industry watchers juggle the twin possibilities of pharmaceutical import tariffs and potential drug pricing ...

Under his “Big Ugly Bill,” the richest Americans are projected to receive at least $12,000 in the form of tax cuts and other subsidies from the American people and their tax money. By comparison, it ...

A new bill to improve the way Medicare Advantage (MA) providers determine patients’ health risks, to eliminate overpayment.

GOP lawmakers in 10 states have refused for a decade to expand Medicaid under the Affordable Care Act. But when President Trump got another whack at Obamacare, these holdout states went unrewarded.

President Donald Trump has introduced a new effort to help Americans more easily share their health records with doctors, using new technology and AI tools.

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

Dr. Mehmet Oz, the Administrator of the Centers for Medicare and Medicaid Services, discussed the impending changes to the ...